BP000238-CYT-420: Recombinant Human Placenta Growth Factor-2 (PLGF 2)
Source: Insect Cells-derived.
Recombinant human PlGF-2 can bind to immobilized rh-sFlt-1 (100 ng/well) with a linear range at 0.3?0 ug/ml.
Purity > 80%, by SDS-PAGE and RP-HPLC.BP000258-CYT-262: Recombinant Rat Vascular Endothelial Growth Factor C (VEGF-C) Protein
Source: Sf9, Insect Cells-derived.
Measured by its ability to stimulate phosphorylation of the VEGFR-3/FLT-4 receptor in porcine aortic endothelial cells. The ED50 for this effect is typically 200-300 ug/ml corresponding to a Specific Activity of 3,334-5,000 IU/mg.
Purity: > 90% by SDS-PAGE and RP-HPLC.BP000258-CYT-284: Recombinant Rat Vascular Endothelial Growth Factor C (VEGF-C) Protein
Source: Sf9, Insect Cells-derived.
Measured by its ability to stimulate phosphorylation of the VEGFR-3/FLT-4 receptor in porcine aortic endothelial cells (PAE/FLT -4 cells). The ED50 for this effect is typically 150-300 ug/ml, corresponding to a specific activity of 3.3-6.6 KUnits/mg.
Purity: > 90% by SDS-PAGE and RP-HPLC.BP000258-CYT-527: Recombinant Human Vascular Endothelial Growth Factor C (VEGF-C) Protein
Source: Sf9, Insect Cells-derived.
Measured by its ability to bind to the VEGFR-3/FLT-4 receptor in the Ba/F3-hVEGFR-3 assay. The ED50 in this assay is about 4 ug/ml corresponding to a Specific Activity of 250,000 IU/mg.
Purity: > 90% by SDS-PAGE and RP-HPLC.BP000261-CYT-628: Recombinant Human VEGF-B (Vascular Endothelial Growth Factor B)
Source: E. coli-derived.
Measured in a cell proliferation assay using NIH-3T3 mouse embryonic fibroblast. The ED50 for this effect is < 1 ug/ml corresponding to a specific activity of less than 1,000,000 units/mg.
Purity > 90%, by SDS-PAGE.BP000590-PKA-335: Recombinant Human EGFR Sf9, Active
Source: Baculovirus infected Sf9 cells-derived.
Specific activity: 30 pmol/µgxmin.BP000590-PKA-344: Recombinant Human EGFR Sf9
Source: Sf9 Insect Cells-derived.
Purity > 90%, by SDS-PAGE.BP000988-PKA-234: Recombinant Human VEGFR1 D3
Source: Insect Cells-derived.
The activity of FLT1D1-3 was determined by its ability to abolish the binding of iodinated VEGF to solid surfaces or cell surfaces receptors, and in Far-Western and cross-linking experiments with iodinated VEGF.
Purity > 90%, by RP-HPLC and SDS-PAGE.BP000988-PKA-338: Recombinant Human VEGFR1 D3, His Tag
Source: Insect Cells-derived.
Purity > 95%, by RP-HPLC and SDS-PAGE.BP000989-PKA-235: Recombinant Human VEGFR1 D4
Source: Insect Cells-derived.
The activity of FLT1D1-4 was determined by its ability to abolish the binding of iodinated VEGF to solid surfaces or cell surfaces, and in Far-Western and cross-linking experiments with iodinated VEGF.
Purity > 90%, by RP-HPLC and SDS-PAGE.